EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond the barrier: Physiological determinants of nanoformulation availability in the aging brain

Ruei-Dun Teng, Jui-Ming Sun, Ting-Lin Yen, Rajeev Taliyan, Cheng-Ta Hsieh, Chih-Hao Yang

Ageing Research Reviews · 2026-10 · 121 · 103281

DOI: 10.1016/j.arr.2026.103281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Ruei-Dun Teng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research, T…. Hauptthemen laut MEDLINE: Aging, Brain, Blood-Brain Barrier, Nanomedicine. Die Arbeit nennt 168 Literaturangaben. Gefördert von: Chiayi Christian Hospital, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanomedicine has revolutionized brain-targeted therapeutics; however, most design paradigms remain centered on overcoming the blood-brain barrier while overlooking the dynamic physiological milieu that governs nanoparticle fate after entry. Emerging evidence reveals that barrier penetration alone is insufficient to ensure efficacy, particularly in the aging brain, where vascular stiffness, impaired interstitial flow, reduced glymphatic clearance, and chronic immune activation reshape nanoparticle distribution, retention, and metabolism. Aging introduces structural and functional heterogeneity that can invert design principles validated in young systems, leading to reduced therapeutic performance and unpredictable outcomes. This review integrates current insights into how age-related vascular remodeling, altered cerebrospinal fluid dynamics, and disrupted circadian-metabolic coupling influence nanoformulation performance. We highlight the need for adaptive design strategies, including stimuli-responsive carriers, redox- or enzyme-triggered release systems, and chronopharmacological dosing, that exploit residual rhythmicity and local biochemical cues to optimize delivery. Beyond design, we discuss translational and regulatory implications, emphasizing age-specific protein corona profiling, biomarker-guided patient stratification, and physiologically relevant safety evaluation. Integrating these insights establishes aging not as a confounder but as a biological framework enables the creation of adaptive, context-aware nanomedicines aligned with the evolving physiology of the aging brain which advancing the field toward durable efficacy, enhanced safety, and genuine precision neurotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingBrainBlood-Brain BarrierNanomedicineNanoparticlesHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

Aging brainBBBGlymphatic clearanceNanomedicineNeuroinflammationPrecision neurotherapeutics

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research, Taipei Medical University Hospital, Taipei 110, Taiwan.
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Section of Neurosurgery, Department of Surgery, Ditmanson Medical Foundation, Chia-Yi Christian Hospita…
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research, Cathay General Hospital, Taipei 106, Taiwan.
  • Neuropsychopharmacology Division, Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani, Rajasthan, India.
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Division of Neurosurgery, Department of Surgery, Cathay General Hospital, Taipei City 106, Taiwan; Scho…
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Research Center for Neuroscience, Taipei Medical University, Taipei 110, Taiwan. Electronic address: ch…

Förderung

  • Chiayi Christian Hospital
  • National Science and Technology Council

Zitieren

APA

Teng, R. D., Sun, J. M., Yen, T. L., Taliyan, R., Hsieh, C. T., & Yang, C. H. (2026). Beyond the barrier: Physiological determinants of nanoformulation availability in the aging brain. Ageing Research Reviews, 121, 103281. https://doi.org/10.1016/j.arr.2026.103281

Vancouver

Teng RD, Sun JM, Yen TL, Taliyan R, Hsieh CT, Yang CH. Beyond the barrier: Physiological determinants of nanoformulation availability in the aging brain. Ageing Research Reviews. 2026;121:103281. doi:10.1016/j.arr.2026.103281

BibTeX
@article{Teng2026,
  author = {Teng, Ruei-Dun and Sun, Jui-Ming and Yen, Ting-Lin and Taliyan, Rajeev and Hsieh, Cheng-Ta and Yang, Chih-Hao},
  title = {Beyond the barrier: Physiological determinants of nanoformulation availability in the aging brain},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {121},
  pages = {103281},
  doi = {10.1016/j.arr.2026.103281}
}
Kostenlos starten →